BARDA commits $483m to Moderna for COVID-19 vaccine
Moderna has secured a funding commitment of up to $483m from the US Government agency Biomedical Advanced Research and Development Authority (BARDA) to advance the development of messenger RNA (mRNA) vaccine for novel coronavirus (SARS-CoV-2).